Percent of Patients With 35% and 50% Reduction in FIAS and TCS by Time Point, mITT Population With FIAS and/or TCS at Baseline (n = 33)

DEE Percent of Patients with 35% and 50% reductions in FIAS and TCS

Percent of Patients With 35% and 50% Reduction in FIAS and TCS by Time Point, mITT Population With FIAS and/or TCS at Baseline (n = 33)

Format

PNG

Source

Zynerba Pharmaceuticals, Inc.

Downloads